Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

In-house ELISA screening using a locally-isolated Leptospirain Malaysia: determination of its cut-off points

Authors: Xue Ting Tan, Fairuz Amran, Kee Chee Cheong, Norazah Ahmad

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Leptospirosis is a zoonotic disease caused by Leptospira species and is distributed globally. Microscopic agglutination test (MAT) is the serological ‘gold standard’ for diagnosis of leptospirosis but it is time-consuming and labour-intensive. An alternative serological method that is rapid, sensitive and specific is important for early treatment to reduce morbidity and mortality. The use of local Leptospira isolation may improve the sensitivity and specificity of the test because it may varies from one geographical region to another region. The objective of this study was to determine the sensitivity, specificity and cut-off points for an in-house Immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA) using a locally isolated Leptospiral strain IMR/175 as the antigen for the detection of anti-Leptospiral IgM.

Methods

Serum samples from 270 patients with clinical symptoms of leptospirosis were subjected to the in-house IgM ELISA, MAT and Leptospirosis rapid test. The optimal cut-off values for positivity and negativity of the IgM ELISA were determined by Receiver Operating Characteristic curves and mean ± 2 standard deviation (SD) analyses of the ELISA values.

Results

The area under the curve (AUC) which indicates the diagnostic performance of the in-house IgM ELISA was 0.953 (95% Confidence Interval, CI: 0.928, 0.978). The sensitivity and specificity of 90.38% and 87.72% respectively were obtained with the cut-off point of 0.55. A higher sensitivity (96.15%) was obtained when the cut-off point was set at 0.45.

Conclusions

The in-house IgM ELISA assay using local Leptospira isolation was shown to be sensitive and may be suitable to use for the serological diagnosis of leptospirosis for our local hospital setting.
Appendix
Available only for authorised users
Literature
1.
go back to reference Levett PN: Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin Iinfect Dis. 2003, 36: 447-452. 10.1086/346208.CrossRef Levett PN: Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin Iinfect Dis. 2003, 36: 447-452. 10.1086/346208.CrossRef
3.
go back to reference Zavitsanou A, Babatsikou F: Leptospirosis: epidemiology and preventive measures. Health Sci J. 2008, 2 (2): 75-82. Zavitsanou A, Babatsikou F: Leptospirosis: epidemiology and preventive measures. Health Sci J. 2008, 2 (2): 75-82.
4.
go back to reference Lim JK, Murugaiyah VA, Ramli A, Abdul Rahman H, Mohamed N, Shamsudin N, Tan JC: A case study: leptospirosis in Malaysia. WebmedCentral Iinfect Dis. 2011, 2 (12): WMC002764- Lim JK, Murugaiyah VA, Ramli A, Abdul Rahman H, Mohamed N, Shamsudin N, Tan JC: A case study: leptospirosis in Malaysia. WebmedCentral Iinfect Dis. 2011, 2 (12): WMC002764-
5.
go back to reference Lim VKE: Leptospirosis: a re-emerging infection. Malayas J Pathology. 2011, 33 (1): 1-5. Lim VKE: Leptospirosis: a re-emerging infection. Malayas J Pathology. 2011, 33 (1): 1-5.
6.
go back to reference Ahmad SN, Shah S, Ahmad FMS: Laboratory diagnosis of leptospirosis. J Postgrad Med. 2005, 51: 195-200.PubMed Ahmad SN, Shah S, Ahmad FMS: Laboratory diagnosis of leptospirosis. J Postgrad Med. 2005, 51: 195-200.PubMed
8.
go back to reference Desakorn V, Wuthiekanun V, Thanachartwet V, Sahassananda D, Chierakul W, Apiwattanaporn A, Day NP, Limmathurosakul D, Peacock SJ: Accuracy of a commercial IgM ELISA for the diagnosis of human leptospirosis in Thailand. Am J Trop Med Hyg. 2012, 86 (3): 524-527. 10.4269/ajtmh.2012.11-0423.CrossRefPubMedPubMedCentral Desakorn V, Wuthiekanun V, Thanachartwet V, Sahassananda D, Chierakul W, Apiwattanaporn A, Day NP, Limmathurosakul D, Peacock SJ: Accuracy of a commercial IgM ELISA for the diagnosis of human leptospirosis in Thailand. Am J Trop Med Hyg. 2012, 86 (3): 524-527. 10.4269/ajtmh.2012.11-0423.CrossRefPubMedPubMedCentral
9.
go back to reference Levett PN, Branch SL, Whittington CU, Edwards CN, Paxton H: Two methods for rapid serological diagnosis of acute leptospirosis. Clin Diagn Lab Immun. 2001, 8 (2): 349-351. Levett PN, Branch SL, Whittington CU, Edwards CN, Paxton H: Two methods for rapid serological diagnosis of acute leptospirosis. Clin Diagn Lab Immun. 2001, 8 (2): 349-351.
10.
go back to reference Sambasiva RR, Naveen G, Bhalla P, Agarwal SK: Leptospirosis in India and the rest of the world. Braz J Iinfect Dis. 2003, 7 (3): 178-193. Sambasiva RR, Naveen G, Bhalla P, Agarwal SK: Leptospirosis in India and the rest of the world. Braz J Iinfect Dis. 2003, 7 (3): 178-193.
11.
go back to reference Musso D, Scola BL: Laboratory diagnosis of leptospirosis: a challenge. J Microbiol Immunol. 2013, 46: 245-252. 10.1016/j.jmii.2013.03.001. Musso D, Scola BL: Laboratory diagnosis of leptospirosis: a challenge. J Microbiol Immunol. 2013, 46: 245-252. 10.1016/j.jmii.2013.03.001.
12.
go back to reference Effler PV, Bogard AK, Domen HY, Katz AR, Higa HY, Sasaki DM: Evaluation of eight rapid screening tests for acute leptospirosis in Hawaii. J Clin Microbiol. 2002, 40 (4): 1464-1469. 10.1128/JCM.40.4.1464-1469.2002.CrossRefPubMedPubMedCentral Effler PV, Bogard AK, Domen HY, Katz AR, Higa HY, Sasaki DM: Evaluation of eight rapid screening tests for acute leptospirosis in Hawaii. J Clin Microbiol. 2002, 40 (4): 1464-1469. 10.1128/JCM.40.4.1464-1469.2002.CrossRefPubMedPubMedCentral
14.
go back to reference Goris MGA, Leeflang MMG, Boer KR, Goeijenbier ECM Van G, Wagenaar JFP, Hartskeerl RA: Establishment of valid laboratory case definition for human leptospirosis. J Bacteriol Parasitol. 2012, 3 (2): 1000132-10.4172/2155-9597.1000132.CrossRef Goris MGA, Leeflang MMG, Boer KR, Goeijenbier ECM Van G, Wagenaar JFP, Hartskeerl RA: Establishment of valid laboratory case definition for human leptospirosis. J Bacteriol Parasitol. 2012, 3 (2): 1000132-10.4172/2155-9597.1000132.CrossRef
15.
go back to reference Anthony K: Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007, 96 (5): 644-647. 10.1111/j.1651-2227.2006.00178.x.CrossRef Anthony K: Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007, 96 (5): 644-647. 10.1111/j.1651-2227.2006.00178.x.CrossRef
16.
go back to reference El Jalii IM, Bahaman A: A review of human leptospirosis in Malaysia. Trop Biomed. 2004, 21 (2): 113-119.PubMed El Jalii IM, Bahaman A: A review of human leptospirosis in Malaysia. Trop Biomed. 2004, 21 (2): 113-119.PubMed
17.
go back to reference Ministry of Health Malaysia: Guidelines for the Diagnosis, Management, Prevention and Control of Leptospirosis in Malaysia. 2011 Ministry of Health Malaysia: Guidelines for the Diagnosis, Management, Prevention and Control of Leptospirosis in Malaysia. 2011
18.
go back to reference Wuthiekanum V, Sirisukkarn N, Daengsupa P, Sakaraserane P, Sangkakam A, Chierakul W, Smythe LD, Symonds ML, Dohnt MF, Slack AT, Day NP, Peacock SJ: Clinical diagnosis and geographic distribution of leptospiroses. Thailand Emerg Infect Dis. 2007, 13 (1): 124-126. 10.3201/eid1301.060718.CrossRef Wuthiekanum V, Sirisukkarn N, Daengsupa P, Sakaraserane P, Sangkakam A, Chierakul W, Smythe LD, Symonds ML, Dohnt MF, Slack AT, Day NP, Peacock SJ: Clinical diagnosis and geographic distribution of leptospiroses. Thailand Emerg Infect Dis. 2007, 13 (1): 124-126. 10.3201/eid1301.060718.CrossRef
19.
go back to reference Pradutkanchana S, Pradutkanchana J, Khuntikij P: Detection of IgM specific antibody using indirect immunofluorescent assay for diagnosis of acute leptospirosis. J Med Assoc Thai. 2003, 86: 641-646.PubMed Pradutkanchana S, Pradutkanchana J, Khuntikij P: Detection of IgM specific antibody using indirect immunofluorescent assay for diagnosis of acute leptospirosis. J Med Assoc Thai. 2003, 86: 641-646.PubMed
20.
go back to reference Appassakij H, Silpapojakul K, Wansit R, Woodtayakorn J: Evaluation of the immunofluorescent antibody test for the diagnosis of human leptospirosis. Am J Trop Med Hyg. 1995, 52: 340-343.PubMed Appassakij H, Silpapojakul K, Wansit R, Woodtayakorn J: Evaluation of the immunofluorescent antibody test for the diagnosis of human leptospirosis. Am J Trop Med Hyg. 1995, 52: 340-343.PubMed
Metadata
Title
In-house ELISA screening using a locally-isolated Leptospirain Malaysia: determination of its cut-off points
Authors
Xue Ting Tan
Fairuz Amran
Kee Chee Cheong
Norazah Ahmad
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-014-0563-7

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.